PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Minoxidil
Presentation Product Chemical substance Chapter Items dispensed
Minoxidil 5mg tablets
0205010N0AAABAB
Minoxidil (Systemic) Minoxidil Cardiovascular System 2,757
Minoxidil 2.5mg tablets
0205010N0AAAAAA
Minoxidil (Systemic) Minoxidil Cardiovascular System 2,690
Minoxidil 5% foam
1309000H0AAALAL
Minoxidil (Scalp) Minoxidil Skin 1,947
Minoxidil 10mg tablets
0205010N0AAACAC
Minoxidil (Systemic) Minoxidil Cardiovascular System 1,905
Loniten 2.5mg tablets
0205010N0BBAAAA
Loniten Minoxidil Cardiovascular System 50
Loniten 10mg tablets
0205010N0BBACAC
Loniten Minoxidil Cardiovascular System 30
Loniten 5mg tablets
0205010N0BBABAB
Loniten Minoxidil Cardiovascular System 27
Minoxidil 2% solution
1309000H0AAAAAA
Minoxidil (Scalp) Minoxidil Skin 2
Minoxidil 5% solution
1309000H0AAAJAJ
Minoxidil (Scalp) Minoxidil Skin 2
Minoxidil 2% gel
1309000H0AAAKAK
Minoxidil (Scalp) Minoxidil Skin 1
Regaine for Women Regular Strength 2% solution
1309000H0BBADAA
Regaine Minoxidil Skin 1
Boots Hair Loss Treatment Regular Strength 2% solution
1309000H0BCAAAA
Boots Minoxidil Skin No data available
Regaine for Men 2% gel
1309000H0BBAFAK
Regaine Minoxidil Skin No data available
Regaine for Men Extra Strength 5% scalp foam
1309000H0BBAGAL
Regaine Minoxidil Skin No data available
Regaine for Men Extra Strength 5% scalp solution
1309000H0BBABAJ
Regaine Minoxidil Skin No data available
Regaine for Men Regular Strength 2% solution
1309000H0BBAAAA
Regaine Minoxidil Skin No data available
Regaine for Women Once a Day 5% scalp foam
1309000H0BBAHAL
Regaine Minoxidil Skin No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.